Cargando…

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism

BACKGROUND: Ganoderma lucidum is reportedly the best source of traditional natural bioactive constituents. Ganoderma triterpenoids (GTs) have been verified as an alternative adjuvant for treating leukemia, cancer, hepatitis and diabetes. One of the major triterpenoids, Resinacein S, has been found t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Fei-Fei, Gao, Shan-Shan, Huang, Yan-Jie, Zhou, Nian, Feng, Jin-Kai, Liu, Zong-Han, Zhang, Yu-Qing, Yuan, Lu-Yun, Wei, Gang, Cheng, Shu-Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971728/ https://www.ncbi.nlm.nih.gov/pubmed/36866057 http://dx.doi.org/10.3389/fnut.2023.1076569

Ejemplares similares

Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
por: Liao, Mingjuan, et al.
Publicado: (2022)

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
por: Zhang, Lijia, et al.
Publicado: (2022)

The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)—A Systematic Review and Meta-Analysis
por: Rosqvist, Fredrik, et al.
Publicado: (2020)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
por: Day, Kaitlin, et al.
Publicado: (2021)

Association Between Dietary Fiber Intake and Non-alcoholic Fatty Liver Disease in Adults
por: Zhao, Huimin, et al.
Publicado: (2020)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
por: Safari, Zahra, et al.
Publicado: (2023)

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
por: Maestri, Marta, et al.
Publicado: (2023)

The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression
por: Vecchione, Giulia, et al.
Publicado: (2017)

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2022)

Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota
por: Cao, Feiwei, et al.
Publicado: (2023)

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
por: Zambon Azevedo, Vittoria, et al.
Publicado: (2022)

Key Enzymes in Fatty Acid Synthesis Pathway for Bioactive Lipids Biosynthesis
por: Zhuang, Xiao-Yan, et al.
Publicado: (2022)

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
por: Meroni, Marica, et al.
Publicado: (2022)

Editorial: Nutrition in prevention and management of non-alcoholic fatty liver disease
por: Kouvari, Matina, et al.
Publicado: (2023)

Mechanism of Paeoniae Radix Alba in the Treatment of Non-alcoholic Fatty Liver Disease Based on Sequential Metabolites Identification Approach, Network Pharmacology, and Binding Affinity Measurement
por: Luo, Zhiqiang, et al.
Publicado: (2021)

Corrigendum: Key Enzymes in Fatty Acid Synthesis Pathway for Bioactive Lipids Biosynthesis
por: Zhuang, Xiao-Yan, et al.
Publicado: (2022)

Complex Dietary Topologies in Non-alcoholic Fatty Liver Disease: A Network Science Analysis
por: Xia, Yang, et al.
Publicado: (2020)

Identification and chemical profiling of anti-alcoholic liver disease biomarkers of ginseng Huang jiu using UPLC-Q-Orbitrap-HRMS and network pharmacology-based analyses
por: Wu, Yongxi, et al.
Publicado: (2022)

The atherogenic index of plasma: A novel factor more closely related to non-alcoholic fatty liver disease than other lipid parameters in adults
por: Liu, Jia, et al.
Publicado: (2022)

Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression
por: Balbuena, Emilio, et al.
Publicado: (2022)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Mini review: STING activation during non-alcoholic fatty liver disease
por: Li, Honggui, et al.
Publicado: (2023)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
por: Hu, Yu-long, et al.
Publicado: (2023)

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Zhu, Weifeng, et al.
Publicado: (2022)

Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
por: Wu, Qiongbo, et al.
Publicado: (2022)

Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
por: Tokuhara, Daisuke
Publicado: (2021)

Effects of beer, wine, and baijiu consumption on non-alcoholic fatty liver disease: Potential implications of the flavor compounds in the alcoholic beverages
por: Zhou, Yabin, et al.
Publicado: (2023)

The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xing, Wenmin, et al.
Publicado: (2022)

Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
por: Musazadeh, Vali, et al.
Publicado: (2022)

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Yin, Cong, et al.
Publicado: (2021)

Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
por: Sabirin, Faezah, et al.
Publicado: (2022)

Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease
por: Hao, Shiqi, et al.
Publicado: (2022)

Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
por: Cao, Chujin, et al.
Publicado: (2023)

Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data
por: Fu, Liwan, et al.
Publicado: (2023)

Effects of oily fish and its fatty acid intake on non-alcoholic fatty liver disease development among South Korean adults
por: Tan, Li-Juan, et al.
Publicado: (2022)

Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity
por: Lu, Yayun, et al.
Publicado: (2023)

Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Dai, Wei, et al.
Publicado: (2023)

Effects of Different Green Teas on Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice
por: Zhou, Dan-Dan, et al.
Publicado: (2022)

Assessment of Auricularia cornea var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease
por: Zhou, Tiantian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fsd388vdp9lehvm0g09qcadp36